2024
Clear surgical margins as a prognostic indicator for disease recurrence, with no impact on survival rates in patients with myxofibrosarcoma
TOMÁŠ, Tomáš, Vasileios APOSTOLOPOULOS, Lukáš PAZOUREK, Marian KUBÍČEK, Iva ZAMBO et. al.Základní údaje
Originální název
Clear surgical margins as a prognostic indicator for disease recurrence, with no impact on survival rates in patients with myxofibrosarcoma
Autoři
TOMÁŠ, Tomáš (203 Česká republika, domácí), Vasileios APOSTOLOPOULOS (203 Česká republika, domácí), Lukáš PAZOUREK (203 Česká republika, domácí), Marian KUBÍČEK (203 Česká republika, domácí), Iva ZAMBO (203 Česká republika, domácí), Dagmar ADÁMKOVÁ (203 Česká republika, domácí), Pavel ŠLAMPA (203 Česká republika, domácí) a Michal MAHDAL (203 Česká republika, domácí)
Vydání
Scientific Reports, London, NATURE RESEARCH, 2024, 2045-2322
Další údaje
Jazyk
angličtina
Typ výsledku
Článek v odborném periodiku
Obor
30204 Oncology
Stát vydavatele
Velká Británie a Severní Irsko
Utajení
není předmětem státního či obchodního tajemství
Odkazy
Impakt faktor
Impact factor: 4.600 v roce 2022
Organizační jednotka
Lékařská fakulta
UT WoS
001234681100016
Klíčová slova anglicky
myxofibrosarcoma
Příznaky
Mezinárodní význam, Recenzováno
Změněno: 15. 8. 2024 12:19, Mgr. Tereza Miškechová
Anotace
V originále
Myxofibrosarcoma presents an infiltrating growth pattern that results in a high tendency for local recurrence. Clear margin resection is challenging because of microscopic infiltration. The purpose of the present study was to analyze the overall and disease-free survival rates of patients with myxofibrosarcoma and the prognostic factors that determine both survival and disease recurrence. Among the 111 patients included in our study, the 5-year overall survival rate was 65.5%. An age of more than 65 years (hazard ratio [HR] 1.9 [95% confidence interval (CI) 1.4-5.6]; p < 0.001), a tumor size of more than 5 cm (HR 2.8 [95% CI 0.9-8.1]; p = 0.049) and the G3 tumor grade (HR 14.1 [95% CI 2.1-105.0]; p < 0.001) negatively affected overall survival. The 5-year recurrence-free survival rate was 49.4%. R1/R2-type resection (HR 2.4 [95% CI 1.0-5.6]; p = 0.048) had a detrimental effect on tumor recurrence. Clear margins had a positive impact on recurrence-free survival, but did not significantly affect overall patient survival, suggesting that other factors may play a more significant role in determining patient outcomes. A surgical margin of 2 mm was not sufficient to significantly influence the incidence of recurrence. Consequently, a wider surgical margin may be necessary to reduce the risk of myxofibrosarcoma recurrence.